• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of recalcitrant nodular prurigo with tofacitinib.

作者信息

Molloy O E, Kearney N, Byrne N, Kirby B

机构信息

Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.

出版信息

Clin Exp Dermatol. 2020 Oct;45(7):918-920. doi: 10.1111/ced.14320. Epub 2020 Jul 18.

DOI:10.1111/ced.14320
PMID:32484964
Abstract
摘要

相似文献

1
Successful treatment of recalcitrant nodular prurigo with tofacitinib.托法替布成功治疗顽固性结节性痒疹。
Clin Exp Dermatol. 2020 Oct;45(7):918-920. doi: 10.1111/ced.14320. Epub 2020 Jul 18.
2
Comment on 'Successful treatment of recalcitrant nodular prurigo with tofacitinib'.关于“托法替布成功治疗顽固性结节性痒疹”的评论
Clin Exp Dermatol. 2020 Dec;45(8):1068-1070. doi: 10.1111/ced.14379. Epub 2020 Aug 26.
3
Treatment of severe lichen planus with the JAK inhibitor tofacitinib.使用JAK抑制剂托法替布治疗重度扁平苔藓。
J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.
4
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.Janus 激酶抑制剂在炎症性肠病中的未来。
J Crohns Colitis. 2017 Jul 1;11(7):885-893. doi: 10.1093/ecco-jcc/jjx003.
5
Recalcitrant, recurrent aphthous stomatitis treated successfully with tofacitinib.托法替布成功治疗顽固性复发性阿弗他口炎。
Clin Exp Dermatol. 2022 Feb;47(2):447-448. doi: 10.1111/ced.14952. Epub 2021 Oct 18.
6
Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis.Janus激酶抑制剂托法替布是难治性嗜酸性筋膜炎的一种潜在治疗选择。
Clin Exp Rheumatol. 2020 May-Jun;38(3):567-568. Epub 2019 Nov 18.
7
Is tofacitinib a game-changing drug for ulcerative colitis?托法替布是否为溃疡性结肠炎带来变革性药物？
United European Gastroenterol J. 2020 Aug;8(7):755-763. doi: 10.1177/2050640620935732. Epub 2020 Jun 18.
8
Reversal of Alopecia Universalis by Tofacitinib: A Case Report.托法替布治疗全秃症逆转：一例报告
Ann Intern Med. 2016 Nov 15;165(10):750-751. doi: 10.7326/L16-0125.
9
Janus Kinase Inhibition in the Treatment of Prurigo Nodularis.Janus激酶抑制在结节性痒疹治疗中的应用
Dermatitis. 2024 May-Jun;35(3):299-300. doi: 10.1089/derm.2023.0036. Epub 2023 Aug 24.
10
Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation.托法替布成功治疗合并类风湿关节炎的掌跖脓疱病：这种JAK抑制剂对T细胞分化的影响
Clin Immunol. 2016 Dec;173:147-148. doi: 10.1016/j.clim.2016.10.003. Epub 2016 Oct 5.

引用本文的文献

1
Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature.乌帕替尼成功治疗结节性痒疹：一例报告及文献综述
Int Med Case Rep J. 2025 May 28;18:637-644. doi: 10.2147/IMCRJ.S514339. eCollection 2025.
2
Effective Treatment of Prurigo Nodularis With Oral Tofacitinib: A Case Report.口服托法替布有效治疗结节性痒疹：一例报告
Clin Case Rep. 2025 Mar 5;13(3):e70287. doi: 10.1002/ccr3.70287. eCollection 2025 Mar.
3
Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study.
乌帕替尼治疗难治性结节性痒疹：一项前瞻性队列研究。
Allergy Asthma Immunol Res. 2024 Sep;16(5):546-554. doi: 10.4168/aair.2024.16.5.546.
4
Upadacitinib for prurigo nodularis.乌帕替尼用于结节性痒疹。
JAAD Case Rep. 2023 Mar 7;48:131-133. doi: 10.1016/j.jdcr.2023.01.037. eCollection 2024 Jun.
5
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.结节性痒疹：发病机制与潜在治疗靶点。
Int J Mol Sci. 2024 May 9;25(10):5164. doi: 10.3390/ijms25105164.
6
Prurigo: review of its pathogenesis, diagnosis, and treatment.瘙痒症：发病机制、诊断与治疗的综述。
An Bras Dermatol. 2024 Sep-Oct;99(5):706-720. doi: 10.1016/j.abd.2023.11.003. Epub 2024 Mar 16.
7
Successful treatment of refractory prurigo nodularis with abrocitinib.阿布昔替尼成功治疗难治性结节性痒疹。
Clin Case Rep. 2024 Mar 7;12(3):e8606. doi: 10.1002/ccr3.8606. eCollection 2024 Mar.
8
Molecular mechanisms of pruritus in prurigo nodularis.结节性痒疹瘙痒的分子机制。
Front Immunol. 2023 Nov 23;14:1301817. doi: 10.3389/fimmu.2023.1301817. eCollection 2023.
9
A Case of Recalcitrant Prurigo Nodularis with Heightened Expression of STAT 3 and STAT 6 and its Dramatic Response to Tofacitinib.一例伴有STAT 3和STAT 6表达增强的顽固性结节性痒疹及其对托法替布的显著反应
Indian Dermatol Online J. 2023 May 25;14(4):564-566. doi: 10.4103/idoj.idoj_508_22. eCollection 2023 Jul-Aug.
10
Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment.慢性结节性瘙痒症：发病机制和治疗的最新进展。
Int J Mol Sci. 2022 Oct 16;23(20):12390. doi: 10.3390/ijms232012390.